Spectrum Pharmaceuticals ... (SPPI)
NASDAQ: SPPI
· Real-Time Price · USD
1.02
-0.01 (-0.97%)
At close: Jul 31, 2023, 9:56 PM
Spectrum Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 52.37M | 40.37M | 56.26M | 25.51M | 78.68M | 88.54M | 107.44M | 114.57M | 69.52M |
Short-Term Investments | 3.76M | 34.73M | 44M | 42.45M | 10.54M | 12.11M | 26.16M | 44.24M | 93.34M |
Long-Term Investments | n/a | 5.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 245K | -5.81M | 3.66M | 3.8M | 4.35M | 4.64M | 4.42M | 4.33M | 4.36M |
Receivables | 33.64M | 13.61M | 586K | 608K | 639K | 1.03M | 3.86M | 3.53M | 2.86M |
Inventory | 12.86M | 9.23M | 9.37M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.74M | 3.07M | 2.77M | 5.01M | 3.33M | n/a | n/a | n/a | n/a |
Total Current Assets | 105.38M | 101.01M | 112.98M | 73.58M | 93.18M | 103.95M | 140M | 165.71M | 169.21M |
Property-Plant & Equipment | 2.05M | 2.17M | 2.29M | 2.05M | 2.52M | 2.96M | 3.39M | 5.01M | 5.44M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.3M | 2.33M | 5.95M | 5.85M | 6.87M | 7.6M | 7.8M | 9.34M | 9.8M |
Total Assets | 107.67M | 103.34M | 118.93M | 79.43M | 100.05M | 111.55M | 147.8M | 175.04M | 179.01M |
Account Payables | 35.38M | 38.1M | 42.01M | 33.12M | 25.3M | 41.26M | 40.91M | 41.86M | 33.58M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 771K | 761K | 752K | 715K | 1M | 1.28M | 1.45M | 1.32M | 1.42M |
Other Current Liabilities | 2.73M | 3.82M | 6.86M | 7.2M | 12.9M | 10.69M | 14.91M | 13.52M | 12.39M |
Total Current Liabilities | 38.88M | 42.69M | 49.62M | 41.04M | 39.21M | 53.23M | 57.27M | 56.7M | 47.38M |
Long-Term Debt | 28.84M | 28.67M | 28.49M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 13.15M | 4.1M | 4.96M | 4.95M | 5.59M | 10.77M | 11.06M | 9.76M | 9.19M |
Total Long-Term Liabilities | 41.99M | 32.77M | 33.45M | 4.95M | 5.59M | 10.77M | 11.06M | 9.76M | 9.19M |
Total Liabilities | 80.87M | 75.45M | 83.08M | 45.99M | 44.8M | 63.99M | 68.34M | 66.46M | 56.57M |
Total Debt | 28.84M | 29.43M | 29.24M | 715K | 1M | 1.28M | 1.45M | 1.32M | 1.42M |
Common Stock | 205K | 203K | 203K | 185K | 179K | 165K | 164K | 164K | 154K |
Retained Earnings | -1.12B | -1.12B | -1.11B | -1.09B | -1.06B | -1.04B | -1B | -971.12M | -920.99M |
Comprehensive Income | -2.89M | -2.92M | -3.01M | -2.96M | -2.91M | -3.04M | -3.48M | -3.33M | -3.51M |
Shareholders Equity | 26.8M | 27.89M | 35.85M | 33.44M | 55.26M | 47.55M | 79.46M | 108.59M | 122.44M |
Total Investments | 3.76M | 34.73M | 44M | 42.45M | 10.54M | 12.11M | 26.16M | 44.24M | 93.34M |